Virus-Like-Vaccines against HIV

Protection against chronic infections has necessitated the development of ever-more potent vaccination tools. HIV seems to be the most challenging foe, with a remarkable, poorly immunogenic and fragile surface glycoprotein and the ability to overpower the cell immune system. Virus-like-particle (VLP...

Descripción completa

Detalles Bibliográficos
Autores principales: Andersson, Anne-Marie C., Schwerdtfeger, Melanie, Holst, Peter J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874651/
https://www.ncbi.nlm.nih.gov/pubmed/29439476
http://dx.doi.org/10.3390/vaccines6010010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874651/
https://www.ncbi.nlm.nih.gov/pubmed/29439476
http://dx.doi.org/10.3390/vaccines6010010

Ejemplares similares